NL144484B - Werkwijze ter bereiding van een geneesmiddel met anti-anflammatoire werking, alsmede werkwijze ter bereiding van de anti-inflammatoir werkzame aralkylmercaptoaminozuren. - Google Patents

Werkwijze ter bereiding van een geneesmiddel met anti-anflammatoire werking, alsmede werkwijze ter bereiding van de anti-inflammatoir werkzame aralkylmercaptoaminozuren.

Info

Publication number
NL144484B
NL144484B NL686809834A NL6809834A NL144484B NL 144484 B NL144484 B NL 144484B NL 686809834 A NL686809834 A NL 686809834A NL 6809834 A NL6809834 A NL 6809834A NL 144484 B NL144484 B NL 144484B
Authority
NL
Netherlands
Prior art keywords
preparation
anflammatory
action
medicinal product
inflammatory active
Prior art date
Application number
NL686809834A
Other languages
English (en)
Dutch (nl)
Other versions
NL6809834A (de
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of NL6809834A publication Critical patent/NL6809834A/xx
Publication of NL144484B publication Critical patent/NL144484B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C319/00—Preparation of thiols, sulfides, hydropolysulfides or polysulfides
    • C07C319/14—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides
    • C07C319/20—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides by reactions not involving the formation of sulfide groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/32—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • C07D233/76—Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/14—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/56—Radicals substituted by sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/18—Radicals substituted by singly bound hetero atoms other than halogen by sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Manufacture And Refinement Of Metals (AREA)
NL686809834A 1967-07-26 1968-07-11 Werkwijze ter bereiding van een geneesmiddel met anti-anflammatoire werking, alsmede werkwijze ter bereiding van de anti-inflammatoir werkzame aralkylmercaptoaminozuren. NL144484B (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65604167A 1967-07-26 1967-07-26
US72835168A 1968-05-10 1968-05-10

Publications (2)

Publication Number Publication Date
NL6809834A NL6809834A (de) 1969-01-28
NL144484B true NL144484B (nl) 1975-01-15

Family

ID=27097099

Family Applications (1)

Application Number Title Priority Date Filing Date
NL686809834A NL144484B (nl) 1967-07-26 1968-07-11 Werkwijze ter bereiding van een geneesmiddel met anti-anflammatoire werking, alsmede werkwijze ter bereiding van de anti-inflammatoir werkzame aralkylmercaptoaminozuren.

Country Status (12)

Country Link
JP (1) JPS5019543B1 (de)
BE (1) BE718559A (de)
CH (1) CH534138A (de)
DE (1) DE1768964A1 (de)
ES (4) ES356488A1 (de)
FR (2) FR1586146A (de)
GB (1) GB1191042A (de)
IE (1) IE32515B1 (de)
IL (1) IL30369A (de)
NL (1) NL144484B (de)
NO (1) NO124205B (de)
SE (1) SE364040B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE733993A (de) * 1968-06-14 1969-12-03
US4315031A (en) * 1977-09-01 1982-02-09 Science Union Et Cie Thiosubstituted amino acids
FR2434149A1 (fr) * 1978-06-22 1980-03-21 Parcor Nouveaux derives de la l-cysteine
US4246263A (en) * 1979-10-15 1981-01-20 Pfizer Inc. Antiinflammatory and immunoregulatory pyrimidines, their method of use and pharmaceutical compositions
DE3303344A1 (de) * 1983-02-02 1984-08-02 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von n-alkylierten aminosaeuren und deren estern
DE10045831A1 (de) * 2000-09-14 2002-04-04 Gruenenthal Gmbh Thio-Aminosäuren
JP2004509101A (ja) 2000-09-14 2004-03-25 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング β−チオ−アミノ酸類
US10724469B2 (en) 2010-12-29 2020-07-28 Ford Global Technologies, Llc Cylinder block assembly

Also Published As

Publication number Publication date
JPS5019543B1 (de) 1975-07-08
IE32515L (en) 1969-01-26
NO124205B (de) 1972-03-20
CH534138A (de) 1973-02-28
IL30369A (en) 1973-08-29
FR7960M (de) 1970-06-01
SE364040B (de) 1974-02-11
ES372357A1 (es) 1972-01-16
FR1586146A (de) 1970-02-13
NL6809834A (de) 1969-01-28
ES372358A1 (es) 1971-10-16
GB1191042A (en) 1970-05-06
ES356488A1 (es) 1970-04-01
DE1768964A1 (de) 1972-01-27
IE32515B1 (en) 1973-09-05
ES372359A1 (es) 1971-10-16
BE718559A (de) 1969-01-27
IL30369A0 (en) 1968-09-26

Similar Documents

Publication Publication Date Title
NL146485B (nl) Werkwijze ter bereiding van 3-benzoylfenylazijnzuurderivaten bevattende farmaceutische preparaten met een anti-inflammatoire werking en gevormde preparaten verkregen onder toepassing van deze werkwijze.
NL151630B (nl) Werkwijze ter bereiding van een farmaceutisch preparaat met anti-inflammatoire werking.
NL141783B (nl) Werkwijze ter bereiding van een geneesmiddel met antihypertensieve werking.
NL146709B (nl) Werkwijze ter bereiding van een geneesmiddel met beta-adrenolytische werking, de door toepassing van deze werkwijze verkregen geneesmiddelen, alsmede een werkwijze ter bereiding van beta-adrenolytisch werkzame 1-fenoxy-2-hydroxy-3-alkylaminopropaanderivaten.
NL144276B (nl) Werkwijze voor de bereiding van broncholytisch werkzame verbindingen en voor de bereiding van een geneesmiddel met broncholytische werking.
NL162060B (nl) Werkwijze voor de bereiding van 2-gesubstitueerde- -3,3-dimethylcyclopropaancarbonzuren en esters daarvan.
NL139972B (nl) Werkwijze ter bereiding van een geneesmiddel met antiflogistische en analgetische werking.
NL7416805A (nl) Werkwijze ter bereiding van een geneesmiddel met anti-inflammatorische werking.
NL179583C (nl) Werkwijze ter bereiding van een geneesmiddel met anti-inflammatoire werking, en werkwijze ter bereiding van geneeskrachtige aroyl-gesubstitueerde fenylazijnzuurderivaten.
NL161766B (nl) Werkwijze ter bereiding van 3-oxo-6,9,11-trihalogeen- -delta 1,4 pregnadienen, alsmede werkwijze ter vervaar- diging van een geneesmiddel met ontstekingsremmende werking.
NL144484B (nl) Werkwijze ter bereiding van een geneesmiddel met anti-anflammatoire werking, alsmede werkwijze ter bereiding van de anti-inflammatoir werkzame aralkylmercaptoaminozuren.
NL146383B (nl) Werkwijze ter bereiding van anabool werkzame 7alfa-methyl-steroiden van de oestraanreeks, alsmede werkwijze ter bereiding van een farmaceutisch preparaat en gevormd farmaceutisch preparaat.
NL157012B (nl) Werkwijze voor de bereiding van farmaceutische preparaten met anti-inflammatoire werking, aldus verkregen gevormde voortbrengselen, alsmede werkwijze ter bereiding van anti-inflammatoir werkzame heterocyclische verbindingen.
NL165459C (nl) Werkwijze ter bereiding van 1-alkyl 4-fenylchinazolinonen met analgetische en antipyretische werking en antibradykinine- en anti- ontstekingswerkzaamheid en van een gevormd genees- middel.
NL139969B (nl) Werkwijze voor de bereiding van onverzadigde keto-carbonzuren met diuretische en saluretische werking, alsmede werkwijze voor de bereiding van farmaceutische preparaten die deze verbindingen bevatten en de daarbij verkregen gevormde farmaceutische preparaten.
NL145216B (nl) Werkwijze voor de bereiding van een cytostatisch werkzaam geneesmiddel.
NL160835C (nl) Werkwijze ter bereiding van een dehydro-epiandrosteron- -ester, alsmede werkwijze voor het bereiden van een geneesmiddel.
NL139457B (nl) Werkwijze ter bereiding van een geneesmiddel met antipyretische, analgetische, antispasmodische en antiinflammatoire werking.
NL165740C (nl) Werkwijze ter bereiding van farmaceutische preparaten met anti-inflammatoire werking die as-triazinederivaten bevatten, verkregen gevormde preparaten, alsmede werk- wijze ter bereiding van de actieve as-triazine- derivaten.
NL153517B (nl) Werkwijze ter bereiding van gesubstitueerde fenylaceetamiden met anti-inflammatoire, analgetische, antipyretische en uv-lichtabsorberende werking, werkwijze ter bereiding van farmaceutische en kosmetische preparaten, alsmede de gevormde preparaten.
NL148324B (nl) Werkwijze ter bereiding van een geneesmiddel met gestagene werking.
NL138934B (nl) Werkwijze voor het bereiden van een geneesmiddel met anti-inflammatoire werking.
NL154744B (nl) Werkwijze ter bereiding van gestageen werkzame 17beta-mono-esters en 3-enol17beta-diesters van 17alfa-ethinyl-18-methyl-19-nor-testosteron, alsmede werkwijze ter bereiding van een farmaceutisch preparaat en gevormd farmaceutisch preparaat.
NL156129B (nl) Werkwijze voor de bereiding van een preparaat met anti-inflammatoire en analgetische werking, een geneesmiddel met dergelijke werking en werkwijze voor de bereiding van in de kern gesubstitueerde 3-alkoxyfenylazijnzuren.
NL144607B (nl) Werkwijze voor de bereiding van een 5-aryloxy-1h-tetrazool en een werkwijze voor de bereiding van een zoetstof.

Legal Events

Date Code Title Description
V1 Lapsed because of non-payment of the annual fee
NL80 Information provided on patent owner name for an already discontinued patent

Owner name: MERCK